Jazz Pharmaceuticals JAZZ
$230.26 −$6.19 (-2.62%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $230.62 +0.16%
Open$235.19
Prev close$236.45
Day range$227.95 – $238.59
Volume984.7K
Market cap$14.78B
P/E (TTM)68.1
Dividend yield–
Analyst view
ConsensusBuy
Analysts16
Average target$307.13+33.4% vs. price
- Buy 100%
Low $275.00Now $230.26Avg $307.13High $337.00
Recent rating changes
The last 20 actions on file set price targets from $275.00 to $337.00, averaging $309.80.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 16 Nov 2026 | Needham | BUY | $308.00 |
| 13 Nov 2026 | UBS | BUY | $326.00 |
| 13 Nov 2026 | Morgan Stanley | BUY | $324.00 |
| 12 Nov 2026 | Piper Sandler | BUY | $330.00 |
| 3 Nov 2026 | TD Cowen | BUY | $300.00 |
| 3 Nov 2026 | CCORF | BUY | $300.00 |
| 3 Nov 2026 | Wells Fargo | BUY | $300.00 |
| 3 Nov 2026 | Piper Sandler | BUY | $310.00 |
| 3 Nov 2026 | Morgan Stanley | BUY | $319.00 |
| 3 Nov 2026 | Stifel | BUY | $275.00 |
| 3 Nov 2026 | Barclays | BUY | $275.00 |
| 3 Nov 2026 | RBC Capital | BUY | $305.00 |
| 3 Nov 2026 | J.P. Morgan | BUY | $310.00 |
| 2 Nov 2026 | Wells Fargo | BUY | $300.00 |
| 2 Nov 2026 | BofA Securities | BUY | $313.00 |
| 2 Nov 2026 | Morgan Stanley | BUY | $314.00 |
| 2 Nov 2026 | Citi | BUY | $325.00 |
| 28 Oct 2026 | UBS | BUY | $337.00 |
| 28 Oct 2026 | J.P. Morgan | BUY | $300.00 |
| 27 Oct 2026 | Citi | BUY | $325.00 |
No comments yet — be the first to weigh in on JAZZ.
Sign in to join the discussion.